ADAPTIMMUNE THERAPEUTICS-ADR (ADAPY:OTCMKTS)
$0.036 0.001 (2.8571%)
Analysed ADAPTIMMUNE THERAPEUTICS-ADR (ADAPY:OTCMKTS) News Sources
Adaptimmune Announces Changes to Board and Executive Leadership Team
17-11-2025
yahoo.com
Flagship Pioneering Appoints Adrian Rawcliffe as CEO-Partner and CEO of Etiome
08-01-2026
yahoo.com
What is the current price of ADAPTIMMUNE THERAPEUTICS-ADR (ADAPY:OTCMKTS)?
The current price of ADAPTIMMUNE THERAPEUTICS-ADR (ADAPY:OTCMKTS) is $0.036.
ADAPTIMMUNE THERAPEUTICS-ADR (ADAPY:OTCMKTS) absolute price change since previous trading day?
The absolute price change of ADAPTIMMUNE THERAPEUTICS-ADR (ADAPY:OTCMKTS) since the previous trading day is $0.001.
ADAPTIMMUNE THERAPEUTICS-ADR (ADAPY:OTCMKTS) percentage price change since previous trading day?
The percentage price change of ADAPTIMMUNE THERAPEUTICS-ADR (ADAPY:OTCMKTS) since the previous trading day is 2.8571%.
What is the most recent average sentiment score for ADAPTIMMUNE THERAPEUTICS-ADR (ADAPY:OTCMKTS)?
The most recent average sentiment score for ADAPTIMMUNE THERAPEUTICS-ADR (ADAPY:OTCMKTS) is 72 out of 100.
What is the most recent average sentiment for ADAPTIMMUNE THERAPEUTICS-ADR (ADAPY:OTCMKTS)?
The most recent sentiment for ADAPTIMMUNE THERAPEUTICS-ADR (ADAPY:OTCMKTS) is .
SEC-8K** Filing Available For ADAPTIMMUNE THERAPEUTICS-ADR (ADAPY:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.